Full Name
Dr. Richard Gorlick Gorlick
Job Title
MD,
Company
The University of Texas MD Anderson Cancer Center
Speaker Bio
Panel Moderator
Dr. Richard Gorlick is Division Head and Department Chair of Pediatrics, Department Chair ad interim of Sarcoma Medical Oncology in the Division of Cancer Medicine at the MD Anderson Cancer Center, and H. Grant Taylor, M.D., W. W. Sutow, M.D. and Margaret P. Sullivan, M.D. Distinguished Chair in Pediatrics. Dr. Gorlick received his medical degree from Downstate Medical School. He trained at New York-Presbyterian and Memorial Sloan-Kettering Cancer Center, where he began his sarcoma research laboratory and clinical practice. His laboratory is the founding Bone Tumor Resource Laboratory for the Children’s Oncology Group. His molecular pharmacology laboratory is completely focused on osteosarcoma. His laboratory is a member of the NCI-funded Pediatric Preclinical in Vivo Testing (PIVOT) Program and past member of the Pediatric Preclinical Testing Consortium. Dr. Gorlick is involved in clinical trials, in part, as past chair of the Bone Tumor Disease Committee for COG. He is a past president of the Connective Tissue Oncology Society. He is current Chair of the Cancer Prevention and Research Institute of Texas (CPRIT) Advisory Committee on Childhood Cancers. Dr. Gorlick has published more than 304 peer-reviewed papers, reviews and book chapters.
Dr. Richard Gorlick is Division Head and Department Chair of Pediatrics, Department Chair ad interim of Sarcoma Medical Oncology in the Division of Cancer Medicine at the MD Anderson Cancer Center, and H. Grant Taylor, M.D., W. W. Sutow, M.D. and Margaret P. Sullivan, M.D. Distinguished Chair in Pediatrics. Dr. Gorlick received his medical degree from Downstate Medical School. He trained at New York-Presbyterian and Memorial Sloan-Kettering Cancer Center, where he began his sarcoma research laboratory and clinical practice. His laboratory is the founding Bone Tumor Resource Laboratory for the Children’s Oncology Group. His molecular pharmacology laboratory is completely focused on osteosarcoma. His laboratory is a member of the NCI-funded Pediatric Preclinical in Vivo Testing (PIVOT) Program and past member of the Pediatric Preclinical Testing Consortium. Dr. Gorlick is involved in clinical trials, in part, as past chair of the Bone Tumor Disease Committee for COG. He is a past president of the Connective Tissue Oncology Society. He is current Chair of the Cancer Prevention and Research Institute of Texas (CPRIT) Advisory Committee on Childhood Cancers. Dr. Gorlick has published more than 304 peer-reviewed papers, reviews and book chapters.
Speaking At
